Victor Gabriel Sanchez
Expert Contributor
Victor Gabriel Sanchez
CEO
Pragmatec
https://www.linkedin.com/in/victorsanchezpragmatec
https://twitter.com/vsanchezmx
https://www.pragmatec.com.mx/
0
Ahead of the annual global bio convention, Victor Sanchez explains the opportunity for Mexico in this growing industry.
Chronic Obesity Treatment Gains FDA Approval
News Article
The FDA approved a drug to manage chronic obesity and its comorbidities.
Yiannis Mallis
View from the Top
Yiannis Mallis
Vice President and General Manager
Novo Nordisk Mexico
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care.
Yannis Mallis
View from the Top
Yiannis Mallis
Vice President and General Manager
Novo Nordisk Mexico
Novo Nordisk is a Danish pharmaceutical company that is a world-leader in diabetes, growth hormones, and hemophilia.
Morten Vaupel
View from the Top
Morten Vaupel
VP & Director General
Novo Nordisk
The state of obesity and diabetes in Mexico made it a core market for Novo Nordisk.
GLOBAL BIOTECHNOLOGY MARKET REVENUE BY SECTOR
Analysis
Biotechnology companies are powerful players in the pharmaceutical sector due to the strong link between biotechnology and drug discovery process.
Subscribe to Novo Nordisk